Evidence map›Paper›PMID 34567257›Full record

ArticleEcancermedicalscience2021

Value of a breast imaging unit in the detection of breast cancer in Mexico.

Yazmín A Ramírez-Galván, Servando Cardona-Huerta, Guillermo Elizondo-Riojas, Alberto Montemayor-Martínez, Jesús I Morales-Escajeda, Carlos E Herrera-Peña

Abstract read
In one paragraph

Article in Ecancermedicalscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yazmín A Ramírez-GalvánDepartment of Radiology and Imaging, Faculty of Medicine, Hospital Universitario 'Dr. José Eleuterio González', Universidad Autónoma de Nuevo León, Madero y Gonzalitos S/N, Col. Mitras Centro, C.P. 64460, Monterrey, Nuevo León, México.
Servando Cardona-HuertaHospital Zambrano Hellion, Breast Cancer Center, Batallón de San Patricio, San Pedro Garza García, C.P. 66278, México.
Guillermo Elizondo-RiojasDepartment of Radiology and Imaging, Faculty of Medicine, Hospital Universitario 'Dr. José Eleuterio González', Universidad Autónoma de Nuevo León, Madero y Gonzalitos S/N, Col. Mitras Centro, C.P. 64460, Monterrey, Nuevo León, México.
Alberto Montemayor-MartínezDepartment of Radiology and Imaging, Faculty of Medicine, Hospital Universitario 'Dr. José Eleuterio González', Universidad Autónoma de Nuevo León, Madero y Gonzalitos S/N, Col. Mitras Centro, C.P. 64460, Monterrey, Nuevo León, México.
Jesús I Morales-EscajedaFacultad de Medicina, Universidad Autónoma de Nuevo León, Madero y Gonzalitos, Monterrey, C.P. 64460, México.
Carlos E Herrera-PeñaFacultad de Medicina, Universidad Autónoma de Nuevo León, Madero y Gonzalitos, Monterrey, C.P. 64460, México.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The screening breast cancer detection rate in Mexico is low. The main objective of this study was to determine the breast cancer detection rate in a Mexican population that attended a breast imaging unit, in which the same radiologist comprehensively evaluated and interpreted breast imaging studies. A total of 5,429 mammograms performed between 2015 and 2016 were evaluated. Rates for biopsy indication, biopsies performed and positive biopsies for cancer were determined. The malignancy detection rate, after a comprehensive imaging evaluation in a breast imaging unit, was 24.3 per 1,000 mammograms. In symptomatic women was 52.9 per 1,000 mammograms, and in screening women was 11.1 per 1,000 mammograms. Breast imaging units in which a comprehensive imaging approach is performed represent an opportunity for low- and middle-income countries without population-based screening programs to achieve a more efficient detection of breast cancer, without generating a higher cost.

Indexed as

biopsybreast neoplasmsdeveloping countriesearly detection of cancerfemalehumansmammographymass screeningMexicoradiologists

Identifiers

PMID34567257
PMCPMC8426018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.